Glenmark Pharmaceuticals Limited (NSE:GLENMARK)
India · Delayed Price · Currency is INR 1,861.90
-2.50 (-0.13%)
Oct 17, 2025, 3:30 PM IST
Glenmark Pharmaceuticals Market Cap
Glenmark Pharmaceuticals has a market cap or net worth of 525.43 billion as of October 17, 2025. Its market cap has increased by 11.26% in one year.
Market Cap
525.43B
Enterprise Value
533.10B
Revenue
134.56B
Ranking
n/a
PE Ratio
69.74
Stock Price
1,861.90
Market Cap Chart
Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 525.43B, an increase of 45,617.24%. That is a compound annual growth rate of 28.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 525.43B | 15.72% |
| Dec 31, 2024 | 454.07B | 88.44% |
| Dec 29, 2023 | 240.96B | 101.33% |
| Dec 30, 2022 | 119.68B | -19.75% |
| Dec 31, 2021 | 149.14B | 7.10% |
| Dec 31, 2020 | 139.25B | 42.03% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,971.14B |
| Divi's Laboratories | 1,744.92B |
| Cipla | 1,259.06B |
| Apollo Hospitals Enterprise | 1,125.26B |
| Mankind Pharma | 1,009.48B |
| Zydus Lifesciences | 983.39B |
| Fortis Healthcare | 821.09B |
| Alkem Laboratories | 665.56B |